BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 927 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $736,000 | -8.5% | 11,310 | -9.1% | 0.55% | -4.4% |
Q4 2017 | $804,000 | -27.2% | 12,444 | -29.3% | 0.57% | -32.0% |
Q3 2017 | $1,105,000 | +4.3% | 17,607 | +0.6% | 0.84% | +1.0% |
Q2 2017 | $1,059,000 | +12.9% | 17,499 | -3.3% | 0.83% | +10.2% |
Q1 2017 | $938,000 | +8.1% | 18,092 | -7.6% | 0.76% | +15.2% |
Q4 2016 | $868,000 | -30.9% | 19,587 | -25.8% | 0.66% | -33.3% |
Q3 2016 | $1,256,000 | +5.0% | 26,386 | -0.2% | 0.98% | +5.5% |
Q2 2016 | $1,196,000 | +12.0% | 26,441 | +1.7% | 0.93% | +10.7% |
Q1 2016 | $1,068,000 | +28.2% | 25,988 | +19.1% | 0.84% | +24.2% |
Q4 2015 | $833,000 | +15.5% | 21,828 | -0.6% | 0.68% | +20.4% |
Q3 2015 | $721,000 | -48.4% | 21,956 | +10.0% | 0.56% | -47.8% |
Q2 2015 | $1,396,000 | +5.4% | 19,960 | +3.3% | 1.08% | +7.8% |
Q1 2015 | $1,324,000 | +24.7% | 19,326 | +33.4% | 1.00% | +25.1% |
Q4 2014 | $1,062,000 | – | 14,484 | – | 0.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |